Unique Cell Platform Ferrologix offers a magnetic based instrument and disposable cartridge for transport, filtration, and organization of single cells, presenting a differentiated platform for precision analysis and therapeutic manufacturing that can be leveraged by diagnostics and cell therapy developers.

Digital Magnetic Sorting Pioneering Digital Magnetic Sorting (Ratcheting Cytometry) suggests potential collaboration or licensing opportunities with research and clinical developers seeking scalable single-cell handling to accelerate precision medicine, next-gen diagnostics, and cellular therapies.

Early-Stage Funding Current funding of $225K and revenue under $1M indicate a seed-stage company with growth needs; potential partners could provide strategic investment, grants, or customer-funded pilots to expand market reach.

Biotech Focused Stack Technology stack aligned with modern cloud, collaboration, and analytics tools (Google Cloud, Workspace, Sentry) facilitates potential integrations with enterprise data pipelines, LIMS, or cloud-based analytics used by biotechs and contract research organizations.

Target Market Fit Small team size with a focus on diagnostics, therapeutics, and cellular manufacturing positions Ferrologix to partner with mid-to-large diagnostics firms, biopharma companies, and CROs seeking novel single-cell purification and scalable workflows.